Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity a phase 1 dosing study

David K. Wallace, Raymond T. Kraker, Sharon F. Freedman, Eric R. Crouch, Amy K. Hutchinson, Amit R. Bhatt, David L. Rogers, Michael B. Yang, Kathryn M. Haider, Deborah K. Van Der Veen, R. Michael Siatkowski, Trevano W. Dean, Roy W. Beck, Michael X. Repka, Lois E. Smith, William V. Good, Mary Elizabeth Hartnett, Lingkun Kong, Jonathan M. Holmes